Genotoxic stress caused by carcinogens like Cigarette smoke activate both the MAPK pathway and the S phase checkpoint in Schizosaccharomyces pombe. But the cross talk between these two pathways has not been investigated in great detail in fission yeast. This study deals with the molecular mechanism of co-ordination between the two regulatory pathways. We show that both the pathways have a common effector molecule, namely Cdc25, the cell cycle regulatory phosphatase. We demonstrate that the MAPK Sty1 interacts with Cdc25 and prevents mitotic entry in S. pombe cells exposed to CSE. To our knowledge, this is the first demonstration of interaction between Sty1 and Cdc25 in S. pombe. The functional significance of this interaction lies in effecting Cdc25 turnover after CSE exposure in S. pombe. We show that Cdc25 turnover after CSE treatment is dependent on the presence of Rad3 activity and Sty1-Cdc25 interaction. Our study suggests that the Cigarette Smoke Extract (CSE) induced stress is counteracted by the simultaneous activation of a mitotic checkpoint in addition to the previously described S phase checkpoint. We also show that Sty1 activity is not essential for activation of the S phase checkpoint.
Introduction
The DNA damage detection, repair and checkpoint activation pathways are evolutionarily conserved from yeast to human to an appreciable extent, as are the stress responsive MAPK pathways. Specifically the major players in these pathways in mammals have their well described homologues in S. pombe. This makes S. pombe a very good model system for studying the cellular responses to various stress conditions including DNA damage, as the extrapolation of the results to mammalian systems is sufficiently relevant. We have already established S. pombe as a model system for studying the cellular responses to Cigarette Smoke Extract (CSE) (Chaudhuri et al. 1 ).
Cigarette Smoke (CS) has been classified as a group A carcinogen and smoking is known to be associated with a variety of diseases like emphysema, chronic obstructive pulmonary disease, atherosclerosis, cardiovascular diseases, neurodegenerative diseases and different types of cancer, most importantly lung cancer (Sherman CB 2 ). Thus elucidation of the intricate molecular interactions that help the cell to survive after being exposed to CS are necessary to understand the mechanism of CS induced disease progression. Cigarette smoke contains 4,700 chemical compounds including sixty known carcinogens and many oxidants and free radicals that are capable of initiating or promoting oxidative damage. Apart from the oxidants present in cigarette smoke, the reactive oxygen species generated by the activated phagocytes following smoking, may also be responsible for the observed oxidative damage (Chow CK 3 ) . The high level of oxidative potency of cigarette smoke accounts for its capacity to oxidize proteins (reviewed in refs. 4-6;) , lipids (reviewed in refs. 5 and 7), and DNA (reviewed in refs. [8] [9] [10] . It has been demonstrated to induce chromosomal aberrations (Hirao et al. 11 ), sister chromatid exchange (Lambert et al. 12 ) and DNA damage including single strand break (reviewed in refs. 13 and 14) . Cumulatively, these effects can cause extensive damage to tissues and organs (Panda et al. 15 ) and potentially contribute to different diseases associated with smoking.
Our previous studies have shown that treatment with sub-lethal doses of CSE leads to S phase checkpoint activation as well as the MAPK Sty1 activation in S. pombe. The S phase checkpoint activation is dependent on Rad3, which is homologous to the mammalian ATM/ATR family of protein kinases. The activation of Rad3 initiates the activation/inhibition of a series of downstream effector molecules including Cds1, which ultimately leads to cell cycle arrest and damage repair. Cell cycle progression in S. pombe requires the activity of the cyclin dependent kinase Cdc2, which is very tightly regulated. The tyrosine kinases Wee1 and Mik1 can phosphorylate Cdc2 on Tyr15 thereby inhibiting its activity (reviewed in refs. [16] [17] [18] . Cdc25 phosphatase can remove this inhibitory phosphorylation and activate Cdc2 (reviewed in refs. [19] [20] [21] . In turn Cdc25 activity is regulated by a negative regulatory phosphorylation by the kinases Chk1 and Cds1 under the conditions of incomplete replication or DNA damage (Furnari et al. 22 ). The MAPK Sty1 on the other hand, responds to a wide spectrum of stress stimuli. It is the homolog of mammalian p38 and S. cerevisiae Hog1. Interestingly many extracellular stimuli like UV or gamma-radiation, DNA damaging compounds etc. have been shown to effect cell cycle checkpoint activation in a p38 dependent manner in mammalian cells (reviewed in refs. [23] [24] [25] [26] [27] [28] [29] . Sty1 also has been shown to link cell cycle progression with environmental stress in S. pombe (reviewed in refs. [30] [31] [32] , but the exact molecular mechanism is not known, except when the inhibition of Cdc25 occurs through the activity of the Srk1 kinase which is dependent on Sty1 for its activation (Lopez-Aviles et al. 33 ). Srk1 however cannot regulate Cdc25 when cells are exposed to genotoxic stress.
In this report we provide evidences, which suggest that both the Rad3-Cds1 dependent S phase checkpoint pathway and the Sty1 MAPK pathway independently regulate the activity of Cdc25 to synergize the cellular responses towards CSE treatment, thus ensuring full protection. We show that Sty1 can physically associate with Cdc25 in vivo in CSE treated S. pombe cells and inhibit mitotic entry of CSE exposed fission yeast cells, and that this association is required for degradation of Cdc25 after CSE treatment. Importantly, association of Cdc25 and Sty1 was also found in fission yeast cells treated with HydroxyUrea also indicating a more general role for this association. The investigation of possible cross talks between MAPK activity and cell cycle regulation also shows that neither Sty1 nor its downstream effector Atf1 can inhibit Cds1 activation in CSE treated cells.
Results
Δrad3Δsty1 cells are highly sensitive to CSE. The first indications for a role of Sty1 in cell cycle modulation after CSE treatment came from the observations on the sensitivities of the respective mutants to CSE. Wild type, Δsty1, Δrad3 and Δrad3Δsty1 cells were exposed to 40 ul CSE and cell death was determined by the extent of PI uptake (Fig. 1A) . The Δrad3Δsty1 cells exhibited extreme sensitivity to CSE, much higher than the additive sensitivity of the Δrad3 and Δsty1 cells. Chronic exposure to CSE, rendered the Δrad3Δsty1 mutant completely non-viable (Fig. 1B) . ROS generation profiles of the CSE treated mutants showed similar trends (Fig. 1C) .
S phase checkpoint is intact in Δsty1 cells. The cell sensitivity data strongly indicated the existence of a synergistic interaction between the Rad3 and Sty1 mediated pathways. So we next investigated whether Sty1 could affect the Rad3 dependent S phase arrest in S. pombe cells exposed to CSE. Wild type and Δsty1 cells treated with 40 ul CSE were fixed at definite time intervals, processed (as described in Materials and Methods) and the cell cycle progression was monitored. Intriguingly we observed that both the wild type and Δsty1 mutants showed activation of the S phase checkpoint, wherein CSE treatment causes a fraction of the cells to accumulate with a DNA content intermediate between 1N and 2N (Fig. 2A) . The biochemical hallmark of S phase checkpoint activation in CSE treated S. pombe cells is the activation of the checkpoint kinase Cds1 (downstream of Rad3) (Chaudhuri et al. 1 ). We found that increase in Cds1 activity after CSE treatment was not affected by the deletion of either Sty1 or its downstream effector Atf1 (data not shown). Hence loss of sty1 activity does not compromise the CSE induced S phase delay in S. pombe. So any possible synergistic interaction between the two pathways is not affecting the S phase checkpoint activation after CSE treatment.
Sty1 regulates mitotic progression in CSE treated cells. Now that we knew that Sty1 was not affecting the S phase delay, we went on to investigate what else could be the overlapping role of Sty1 with the cell cycle regulatory pathway in S. pombe. To this end we searched for any enhanced cell division defects in CSE treated Δsty1 cells. It was observed that the CSE treated Δsty1 cells exhibit multiple and abnormal septation (Fig. 3A , part iii), a phenotype that is highly However CSE treated Δrad3 cells also did not undergo abnormal mitosis. Hence the mechanism for repair or prevention of aberrant mitosis does not appear to be dependent on the activation of the S phase checkpoint following CSE treatment. However this repair appeared to be severely impaired in both Δsty1 and Δsty1Δrad3 cells. Hence Sty1 must be having a role in ensuring that mitotic aberrations did not accumulate in CSE treated S. pombe cells. To investigate what this role was, asynchronously growing wild type and Δsty1 cells were treated with CSE and the growth and mitotic progression of both cell populations was monitored. We observed that there is a significant growth arrest in both wild type and Δsty1 cells after CSE treatment (Fig. 3B ). Mitotic progression was determined and expressed as the Mitotic index, i.e., the percentage of single, non-septate, binucleate cells in the population. We found that CSE treatment causes an appreciable decrease in mitotic index in the wild type population within 30 mins of exposure (Fig. 3C , part i), whereas a comparable decrease in the mitotic index of CSE treated Δsty1 wasn't seen before at least 1.5 hrs post CSE exposure (Fig. 3C, part ii) , although in case of both the cell types the cells number ceases to increase after CSE treatment (Fig. 3B) . These results clearly show that Sty1 is required for slowing down mitotic progression in CSE treated cells and in absence of this Sty1 mediated delay, the cells undergo aberrant mitosis, thus leading to mitotic catastrophe. So S. pombe cells respond to CSE treatment by activating two defense strategies, namely the slowed mitotic progression and the slowing of S phase. Absence of both these pathways in the Δrad3Δsty1 renders them extremely sensitive to CSE. Sty1 associates with Cdc25 in vivo. The next logical step was obviously to probe into the molecular mechanism by which Sty1 activates a mitotic checkpoint. Now, if Sty1 has to bring about a cell cycle delay, it has to directly or indirectly affect the regulation of any of the important cell cycle regulatory molecules. One prime suspect was the cell cycle regulatory phosphatase Cdc25. The reasons behind implicating Cdc25 was that Sty1 being a Ser/Thr Kinase had the potential to inhibit Cdc25, as the latter is known to be inactivated after Ser phosphorylation. Chances were that if Sty1 could function in Cdc25 inhibition then we might find Cdc25 associated with Sty1 in CSE treated S. pombe cells. So, total Sty1 was immunoprecipitated from CSE treated wild type KS1376 S. pombe cells (which have a HAtagged genomic copy of Sty1) at different times after treatment and transferred onto PVDF membrane. Imunoblotting with anti Cdc25 antibodies revealed the presence of associated Cdc25 with the immunoprecipitated Sty1 (Fig. 4A) , thus confirming our suspicions. The extent of this association peaked at 10 mins after treatment. Sty1 activation after CSE treatment has been shown to be maximal around this time also (Chaudhuri et al. 1 ). aggravated in the Δrad3Δsty1 mutants (Fig. 3A, part iv) . Such abnormalities are not observed in either wild type (Fig. 3A, part i) or the Δrad3 (Fig. 3A, part ii) Thus CSE treatment activates Sty1, which can then associate with Cdc25 and inhibit its activity, thus blocking the cells' entry into mitosis. Genetic studies in S. pombe have earlier pointed to a link between Sty1 and Cdc25 activity but this study, to our knowledge, is the first report of direct interaction between Sty1 and Cdc25 in S. pombe in vivo. Further investigation is however needed to confirm whether this interaction leads to any direct or indirect modification of Cdc25. Reverse immunoprecipitation experiments where Cdc25 was immunoprecipitated from CSE treated wild type cells and then immunoblotting was done using anti p38 antibodies confirmed this interaction (data not shown). So we knew now how Sty1 was bringing about the delayed mitotic progression. It was necessary to find out whether this function of Sty1 was in any ways modulated by Rad3. While investigating such a possibility we actually found that Cdc25 immunoprecipitated from Δrad3 cells treated with CSE was still found to be associated with Sty1 but unlike the case for the wild type cells, there was a significant continuation of this association upto 30 mins after treatment (Fig. 4B) . Hence although Rad3 activity is not essential for initiating the interaction between Sty1 and Cdc25, but temporal regulation of this interaction definitely depends on Rad3 activity. Wild type S. pombe cells were then subjected to stress condition other than CSE and it was found that the associtation of Sty1 with Cdc25 is not CSE specific. The Sty1 -Cdc25 interaction was present in HU treated cells and to a much lesser extent in H 2 O 2 treated cells (Fig. 4C) .
CSE induced Cdc25 degradation depends on Sty1-Cdc25 interaction. The demonstration of this novel interaction between Sty1 and Cdc25 made it important to look for its functional significance. Wild type, Δsty1 and Δrad3 cells were separately treated with CSE and cells were harvested at 0, 10, 20, 30 and 60 minutes after treatment. Denatured extracts were prepared and equal amounts of total protein from these extracts were resolved on 10% SDS-PAGE. Subsequently Cdc25 levels were monitored by immunoblotting. It was observed that when wild type S. pombe cells are treated with CSE, there is a rapid decrease in the total Cdc25 levels (Fig. 5A ). Hence treatment with CSE leads to degradation of Cdc25 resulting in the observed cell cycle arrest. Interestingly under similar conditions there is no Cdc25 degradation at all in Δsty1 cells (Fig. 5B) . Even in Δrad3 cells there is only a slight decrease in total Cdc25 levels, at 60 mins after CSE treatment (Fig. 5C ). Expectedly, in Δrad3Δsty1 cells the Cdc25 levels remain fairly constant (Fig. 5D) .
Hence the CSE mediated degradation of Cdc25 was impaired in the absence of either Sty1 or Rad3 activity. Rad3 mediated Cdc25 degradation in S. pombe during S phase arrest is well documented. Here we show that both Rad3 dependent inhibition of Cdc25 and the interaction between Sty1 and Cdc25 are equally important for effecting the Cdc25 degradation and cell cycle arrest resulting from CSE treatment.
We investigated whether this Cdc25 degradation is reflected in Cdc2 activity. We found that the levels of inhibitory Tyr 15 phosphorylation on Cdc2 show an oscillating pattern in CSE treated wild type cells (Fig. 6A) , while it remains constant in Δsty1 (Fig. 6B ) cells under similar conditions. This shows that there might be a more complex role of Sty1 in the regulation of Cdc2 activity, probably mediated through Wee1 or Mik1 kinases. This possibility however needs further investigation.
Discussion
In this report we demonstrate a novel pathway of modulation of cell cycle regulatory molecules in S. pombe, namely, the activation of a mitotic checkpoint by the MAPK Sty1.
Interstingly many extracellular stimuli like UV or gamma-radiation, DNA damaging compounds etc have been shown to activate cell cycle checkpoints in a p38 dependent manner in mammalian cells. p38 has been demonstrated to bind and phosphorylate Cdc25B, Cdc25C and Cdc25A (Bulavin et al., 24 Lemaire et al., 25 Kittipatarin et al. 36 ). ERK has also been shown to phosphorylate Cdc25C (Eymin et al. 37 ). Our data shows that a similar mechanism is present in S. pombe also. We show that MAPK activity is related to Cdc25 turnover in S. pombe. Although a role for Sty1 has long been implicated in Cell cycle regulation in S. pombe, this is the first study illustrating the molecular mechanism behind this regulation. This is the first report demonstrating the direct physical association of Sty1 and Cdc25. We show that CSE treated S. pombe cells face two different checkpoints in order to counteract the damage caused by CSE. We had previously shown that CSE treated S. pombe cells are arrested in S phase in a Rad3-Cds1 dependent manner (Chauduri et al. 1 ). We now add that CSE treated S. pombe cells also exhibit a delay in mitotic progression. The activation of this mitotic checkpoint requires the activity of the MAPK Sty1. Sty1 activated in response to CSE slows down mitotic progression in CSE treated S. pombe cells and thus prevents a mitotic catastrophe. Based on the above findings we propose a modified model for cellular response to CSE in S. pombe (Fig. 7) . We show that Sty1 is necessary for the CSE induced delay in mitotic progression in S. pombe cells. This is achieved through the in vivo association of Sty1 with the cell cycle regulatory phosphatase Cdc25 and the resulting degradation of Cdc25. This interaction between Sty1 and Cdc25 is not specific to CSE but is also present in S. pombe cells treated with Hydroxyurea. Thus this mechanism represents a general mode of cell cycle regulation in S. pombe. Both CSE and Hydroxyurea are potent genotoxins. They cause extensive DNA damage which also leads to generation of free radicals inside the cells. Either the DNA damage or the resulting generation of free radicals or both might be responsible for the observed Sty1-Cdc25 interaction. We show that Rad3 activity is important for temporal regulation of the interaction between Sty1 and Cdc25. Our observations suggest that the cell cycle regulatory and the MAPK signaling pathways converge at the common effector molecule, namely the Cdc25 phosphatase. Absence of either of these two pathways increases the cells' sensitivity to CSE and the absence of both is extremely deleterious to cell survival. We also show that there is huge ROS accumulation in the Δsty1Δrad3 double mutant after CSE treatment. It is possible that failure to activate cell cycle checkpoints leads to accumulation of DNA damage in these cells after CSE treatment. This in turn would lead to generation of free radicals as manifested by an increase in intracellular ROS levels. This may also lead to the observed high sensitivity of the Δsty1Δrad3 cells to CSE.
It needs to be mentioned here that Sty1 mediated Cdc25 degradation does not co-relate directly with the levels of inhibitory Tyr15 phosphorylation on Cdc2 (Fig. 6) . This indicates the probable presence of a more complex regulation of Cdc2 activity downstream of or parallel to the Sty1-Cdc25 interaction. The differential levels of phospho Cdc2(Tyr15) in CSE treated Δsty1 and wild type cells suggests that apart from regulating Cdc25 degradation, Sty1 may influence the activity of Cdc2 also. However this possibility needs further investigation.
This study also investigates whether the CSE induced S phase delay is in anyway dependent on MAPK activity. We clearly show that Sty1 does not affect the S phase checkpoint activation. ATF2 the mammalian homologue of S. pombe Atf1, a Sty1 dependent transcription factor has been earlier reported to have a role in regulating the activity of Chk2 (mammalian homologue of S. pombe Cds1) during DNA damage response (Bhoumik et al. 38 ), but we observed that neither Sty1 nor Atf1 activity is essential for Cds1 activation during cellular response to CSE treatment (data not shown).
The association of Sty1 with Cdc25 in CSE treated S. pombe cells implicates a novel role of Sty1 in Cell cycle regulation upon genotoxic stress. The functional significance of this association is seen at the level of Cdc25 degradation in response to CSE. Our studies have clearly demonstrated that both Rad3 dependent inhibition of Cdc25 and the interaction between Sty1 and Cdc25 are significantly important for Cdc25 degradation and cell cycle arrest in response to CSE treatment. This interdependence of Sty1 and Rad3 in regulating Cdc25 turnover is the hallmark of the synergism between the two signaling cascades regulated by the individual proteins. These findings also give an extended insight into how human cells may potentially react to Cigarette smoke exposure. Interaction between their respective homologs in humans, p38 and Cdc25A/B/C respectively in cells treated with CSE has not been reported earlier, but our findings strongly suggest that the activation of p38 might lead to the activation of a similar mitotic checkpoint in human cells exposed to Cigarette smoke. Together these findings elucidate the importance of Sty1/p38 in counteracting genotoxic stress and strengthen the ideas behind the emerging role of p38 as a tumor suppressor (Timofeev et al. 39 ).
Materials and Methods
Fission yeast strains, media and growth conditions. S. pombe strains used in this study are listed in Table 1 . All cells were grown at 30°C in the rich medium (YES), as described previously (Moreno et al. 34 ).
Preparation of cigarette smoke extract (CSE) and CSE treatment. Preparation of CSE and treatment was done as described before (Chaudhuri et al. 1 ). Unless otherwise mentioned all treatments with CSE were done at a dose of 40 ul CSE/8 x 10 6 cells. Fluorescence microscopy. Fission yeast nuclei and septum were stained with 4', 6'-diamidino-2-phenylindole (DAPI) and Calcofluor, respectively, as described previously (Moreno et al. 34 ). After staining, cells were examined using Zeiss LSM 510 Meta Laser Scanning Confocal Microscope at 63X magnification. The mitotic index was determined by counting the percentage of single (non septate) binucleate cells. All images were taken and processed with the use of identical parameters. For all quantitative experiments at least 400 cells were examined in each sample.
Flow cytometry. For cell cycle monitoring, asynchronously growing fission yeast cells were treated with CSE as described above and were fixed in 70% ethanol at indicated time points and stored at 4°C. For measuring DNA content, cells were washed once with 50 mM sodium citrate, then resuspended in the same buffer containing 0.1 mg/ml RNase A (Bangalore Genei) and incubated at 37°C for at least 2 hrs. Cells were then stained with the same buffer supplemented with 4 μg/ml Propidium Iodide and analyzed by a Becton Dickinson FACS Calibur. Data were analyzed by CellQuest software for Macintosh.
For cell death measurement cells treated with CSE were collected at the indicated time points and stained with Propidiun Iodide (without fixing). Only dead cells take up PI. So PI uptake can be used to asses cell death. % of cells having higher PI fluorescence than unstained cells in each case was determined. The data so obtained was normalized with respect to the cell death in untreated cell populations in each strain. The data represent mean of three independent experiments. For ROS level determination cells treated with CSE were collected at the indicated time points, washed in YES and incubated for further 30 mins with 10 uM H 2 DCF-DA. H 2 DCF-DA is a cell permeable substance. Cellular esterases can cleave the ester linkage and convert it into a flourophore trapped inside the cell. Intracellular ROS can then oxidize H 2 DCF to a fluorescent molecule and its fluorescence is thus comparable to intracellular ROS levels. % of cells having higher fluorescence than the unstained cells was determined for each sample. The data represent mean of three independent experiments.
Immunoprecipitations and immunoblotting. Cells were collected by rapid filtration following CSE exposure at indicated time points and cell extracts were made under native conditions. Sty1 was immunoprecipitated from wild type cells using the strain KS1376, which carries a chromosomal copy of Spc1 having a C-terminal tag with two copies of the influenza virus hemagglutinin (HA) epitope followed by six consecutive histidine residues (reviewed in refs. 31 and 35), using anti-HA(12CA5) antibodies (1:100, Santa Cruz). Cdc25 was immunoprecipitated using polyclonal Cdc25A antibodies (1:100, Santa Cruz). Immunocomplexes were resolved by SDS-PAGE and electroblotted to PVDF membrane. Immunoblotting was done with anti Cdc25A antibodies (1:500; Santa Cruz), or anti p38 (1:500, Cell Signalling) as the case may be and then with HRP conjugated Secondary antibody (1:5000; Bangalore Genei) and detected by Chemiluminiscence using 20X LumiGLO ® Reagent and 20X Peroxide (Cell Signalling Technology). 
